The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Catch up with the latest episode of Coast & Country where Andrew meets the sleddog racing team and Ruth goes weather watching in Snowdonia.
What a week it's been! We started with exceptionally warm temperatures, braved Doris and now it looks like we're in for a wet weekend!
Cardiff manager Neil Warnock has agreed to stay on at the City Stadium, whilst Swansea boss Paul Clement prepares for a return to Chelsea.